Ikarian Capital, LLC 13D and 13G filings for Kazia Therapeutics Ltd ADR:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 9:05 pm Sale | 2026-06-30 | 13G | KAZIA THERAPEUTICS LTD SPONSOR KZIA | Ikarian Capital, LLC | 575,778 4.900% | -4,976 (-0.86%) | Filing |
| 2026-02-17 5:47 pm Purchase | 2025-12-31 | 13G | KAZIA THERAPEUTICS LTD SPONSOR KZIA | Ikarian Capital, LLC | 580,754 5.100% | 580,754 (New Position) | Filing |